|
🐬
|
The ABCs of membrane transporters in health and disease (SLC series): Introduction
M. Hediger,
Benjamin Clémençon,
R. Burrier,
E. Bruford
|
9 |
2013 |
9
🐬
|
|
🐜
|
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
35 auth.
D. Basketter,
H. Clewell,
I. Kimber,
A. Rossi,
B. Blaauboer,
R. Burrier,
Mardas Daneshian,
C. Eskes,
A. Goldberg,
N. Hasiwa,
S. Hoffmann,
J. Jaworska,
T. Knudsen,
R. Landsiedel,
M. Leist,
...
P. Locke,
G. Maxwell,
J. Mckim,
E. McVey,
G. Ouedraogo,
G. Patlewicz,
O. Pelkonen,
E. Roggen,
C. Rovida,
I. Ruhdel,
Michael Schwarz,
A. Schepky,
G. Schoeters,
N. Skinner,
Kerstin Trentz,
Maria Turner,
P. Vanparys,
J. Yager,
J. Zurlo,
T. Hartung
|
7 |
2012 |
7
🐜
|
|
🐬
|
2-Azetidinones as inhibitors of cholesterol absorption.
D. Burnett,
Mary Ann Caplen,
Harry R. Davis,
R. Burrier,
J. Clader
|
7 |
1994 |
7
🐬
|
|
🐢
|
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
13 auth.
P. West,
D. Amaral,
P. Bais,
Alan M. Smith,
Laura A. Egnash,
M. E. Ross,
J. Palmer,
B. Fontaine,
K. Conard,
B. Corbett,
...
G. G. Cezar,
E. Donley,
R. Burrier
|
6 |
2014 |
6
🐢
|
|
🐜
|
GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.
13 auth.
Eric M. Parker,
Carol K Babij,
Ambikaipakan Balasubramaniam,
R. Burrier,
M. Guzzi,
F. Hamud,
Gitali Mukhopadhyay,
M. Rudinski,
Z. Tao,
Melissa A.B. Tice,
...
Ling Xia,
Deborra E. Mullins,
Brian G. Salisbury
|
6 |
1998 |
6
🐜
|
|
🐜
|
2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.
12 auth.
J. Clader,
D. Burnett,
Mary Ann Caplen,
M. Domalski,
S. Dugar,
W. Vaccaro,
...
Rosy Sher,
M. E. Browne,
Hongrong Zhao,
R. Burrier,
Brian G. Salisbury,
Harry R. Davis
|
6 |
1996 |
6
🐜
|
|
🐜
|
Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
16 auth.
Brian G. Salisbury,
Harry R. Davis,
R. Burrier,
D. Burnett,
G. Boykow,
Mary Ann Caplen,
Anthony Clemmons,
D. Compton,
L. Hoos,
D. G. McGregor,
...
Robin Schnitzer-Polokoff,
April A. Smith,
Blair S. Weig,
Deborah L Zilli,
J. Clader,
Edmund J. Sybertz
|
6 |
1995 |
6
🐜
|
|
🐜
|
The sodium-dependent ascorbic acid transporter family SLC23.
8 auth.
Marc Bürzle,
Yoshiro Suzuki,
D. Ackermann,
Hiroki Miyazaki,
N. Maeda,
Benjamin Clémençon,
...
R. Burrier,
M. Hediger
|
6 |
2013 |
6
🐜
|
|
🐜
|
Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder
7 auth.
Alan M. Smith,
Joseph J. King,
P. West,
Michael A. Ludwig,
E. Donley,
R. Burrier,
...
D. Amaral
|
6 |
2019 |
6
🐜
|
|
🐬
|
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Harry R. Davis,
Kathyrn K. Pula,
Kevin B. Alton,
R. Burrier,
Robert W. Watkins
|
6 |
2001 |
6
🐬
|
